» Articles » PMID: 30463913

HoxA9 Transforms Murine Myeloid Cells by a Feedback Loop Driving Expression of Key Oncogenes and Cell Cycle Control Genes

Overview
Journal Blood Adv
Specialty Hematology
Date 2018 Nov 23
PMID 30463913
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Ectopic expression of the oncogenic transcription factor HoxA9 is a major cause of acute myeloid leukemia (AML). Here, we demonstrate that HoxA9 is a specific substrate of granule proteases. Protease knockout allowed the comprehensive determination of genome-wide HoxA9 binding sites by chromatin immunoprecipitation sequencing in primary murine cells and a human AML cell line. The kinetics of enhancer activity and transcription rates in response to alterations of an inducible HoxA9 were determined. This permitted identification of HoxA9-controlled enhancers and promoters, allocation to their respective transcription units, and discrimination against HoxA9-bound, but unresponsive, elements. HoxA9 triggered an elaborate positive-feedback loop that drove expression of the complete -A locus. In addition, it controlled key oncogenic transcription factors and and directly induced the cell cycle regulators and , as well as telomerase, drawing the essential blueprint for perturbation of proliferation by leukemogenic HoxA9 expression.

Citing Articles

Mitochondrial perturbations in low-protein-diet-fed mice are associated with altered neutrophil development and effector functions.

Thind M, Miraglia E, Ling C, Khan M, Glembocki A, Bourdon C Cell Rep. 2024; 43(8):114493.

PMID: 39028622 PMC: 11372442. DOI: 10.1016/j.celrep.2024.114493.


HOXA9 Regulome and Pharmacological Interventions in Leukemia.

Aryal S, Lu R Adv Exp Med Biol. 2024; 1459:405-430.

PMID: 39017854 DOI: 10.1007/978-3-031-62731-6_18.


How to put a hex on HOX.

Slany R Hemasphere. 2024; 8(6):e83.

PMID: 38836099 PMC: 11145742. DOI: 10.1002/hem3.83.


Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

Lambert M, Jambon S, Bouhlel M, Depauw S, Vrevin J, Blanck S Hemasphere. 2024; 8(5):e77.

PMID: 38716146 PMC: 11072194. DOI: 10.1002/hem3.77.


HOXA9 gene inhibits proliferation and differentiation and promotes apoptosis of bovine preadipocytes.

He L, Feng X, Hu C, Liu S, Sheng H, Cai B BMC Genomics. 2024; 25(1):358.

PMID: 38605318 PMC: 11007997. DOI: 10.1186/s12864-024-10231-3.


References
1.
Cusanovich D, Pavlovic B, Pritchard J, Gilad Y . The functional consequences of variation in transcription factor binding. PLoS Genet. 2014; 10(3):e1004226. PMC: 3945204. DOI: 10.1371/journal.pgen.1004226. View

2.
Sun Y, Zhou B, Mao F, Xu J, Miao H, Zou Z . HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. Cancer Cell. 2018; 34(4):643-658.e5. PMC: 6179449. DOI: 10.1016/j.ccell.2018.08.018. View

3.
Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun A . PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Cancer Res. 2016; 76(3):619-29. PMC: 4810030. DOI: 10.1158/0008-5472.CAN-15-1566. View

4.
Heckl D, Kowalczyk M, Yudovich D, Belizaire R, Puram R, McConkey M . Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat Biotechnol. 2014; 32(9):941-6. PMC: 4160386. DOI: 10.1038/nbt.2951. View

5.
Garcia-Cuellar M, Buttner C, Bartenhagen C, Dugas M, Slany R . Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes. Cell Rep. 2016; 15(2):310-22. DOI: 10.1016/j.celrep.2016.03.018. View